Welcome to Molecular Design Laboratory

The Molecular Design Lab was created in September 2009 at the Department of Pathophysiology, Shanghai JiaoTong University School of Medicine. Our research interests focus on drug discovery using the combination of drug design, bioinformatics, medicinal chemistry and chemical biology methods. Specially, we developed a series of allosteric methods including recognition of allosteric target, identification of allosteric site and allosteric drug screening to overcome potential selectivity and toxicity in the drug discovery. Inspired by the advantage of the methods, novel allosteric activators/inhibitors were discovered in several drug targets and used to address the challenges of finely-tuned biological regulation and human disorder treatment and medicine.

News

2017 New paper accepted: The paper titled "Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration" has been accepted by Nature Chemical Biology.
2017 New paper accepted: The paper titled "Proteome-scale investigation of protein allosteric regulation perturbed by somatic mutations in 7,000 cancer genomes" has been accepted by The American Journal of Human Genetics.
2017 New paper accepted: The paper titled "Intrinsic protein disorder in oncogenic KRAS signaling" has been accepted by Cellular and Molecular Life Sciences.
2017 New paper accepted: The paper titled "Ras conformational ensembles, allostery and signaling" has been accepted by Chemical Reviews.
2016 New paper accepted: The paper titled "ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks" has been accepted by Nucleic Acids Research.